The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
BPC-157 se ha convertido en objeto de un inters cientfico sustancial principalmente debido a su aparente actividad pleiotrpica en mltiples sistemas de tejidos y rganos en modelos animales
Functional medicine looks at how your entire system works together: gut, thyroid, liver, stress response, and reproductive hormones
The company is enrolling 150 people with a BMI of 20 or higher who want to microdose for health and longevity with no intention of losing weight
Integrated colon microbiome and metabolomics to elucidate the antidepressant mechanisms of the radix bupleuri-radix paeoniae alba herb pair
Had no side effects.
.jpg)
